Clinical pharmacokinetics of ketoprofen and its enantiomers.
about
Enantiospecific ketoprofen concentrations in plasma after oral and intramuscular administration in growing pigsSpray-dried microspheres containing ketoprofen formulated into capsules and tablets.Stereoselective binding of mexiletine and ketoprofen enantiomers with human serum albumin domainsThe influence of renal function on the enantioselective pharmacokinetics and pharmacodynamics of ketoprofen in patients with rheumatoid arthritis.Pharmacokinetics of ketoprofen enantiomers after different doses of the racemateEfficacy and safety of epicutaneous ketoprofen in Transfersome (IDEA-033) versus oral celecoxib and placebo in osteoarthritis of the knee: multicentre randomised controlled trial.Pain management for dentists: the role of ibuprofen.Distinguishing between the permeability relationships with absorption and metabolism to improve BCS and BDDCS predictions in early drug discoveryMulti-functional scaling methodology for translational pharmacokinetic and pharmacodynamic applications using integrated microphysiological systems (MPS).Zidovudine, diclofenac and ketoprofen pharmacokinetic interactions in rats.Use of a robust dehydrogenase from an archael hyperthermophile in asymmetric catalysis-dynamic reductive kinetic resolution entry into (S)-profens.Stereochemical aspects of pharmacotherapy.Enantioselective assays in comparative bioavailability studies of racemic drug formulations: nice to know or need to know?New insights into the site and mode of antinociceptive action of flurbiprofen enantiomers.Application of gastrointestinal simulation for extensions for biowaivers of highly permeable compounds.Evaluation of alginate compressed matrices as prolonged drug delivery systems.Ketoprofen and prednisolone do not modulate neutrophil CR1, CR3 and Fc gamma RIII expression in healthy volunteers.Elucidating the role of dose in the biopharmaceutics classification of drugs: the concepts of critical dose, effective in vivo solubility, and dose-dependent BCS.Enantiomeric fraction determination of 2-arylpropionic acids in a package plant membrane bioreactor.Ketoprofen 75 mg qid versus acetaminophen 1000 mg qid for 3 days on swelling, pain, and other postoperative events after third-molar surgery.Pharmacokinetic parameters and milk concentrations of ketoprofen after administration as a single intravenous bolus dose to lactating goats.Ketoprofen pharmacokinetics of R- and S-isomers in juvenile loggerhead sea turtles (Caretta caretta) after single intravenous and single- and multidose intramuscular administration.Characterization and quantification of metabolites of racemic ketoprofen excreted in urine following oral administration to man by 1H-NMR spectroscopy, directly coupled HPLC-MS and HPLC-NMR, and circular dichroism.Pharmacokinetics and Pharmacodynamics of (S)-Ketoprofen Co-Administered with Caffeine: A Preclinical Study in Arthritic Rats.Analgesic properties of dexketoprofen trometamol.Analgesic, Antiinflammatory, and Antipyretic Effects of S(+)-Ketoprofen In Vivo.Bioavailability of S(+)-Ketoprofen After Oral Administration of Different Mixtures of Ketoprofen Enantiomers to Dogs.Stereoselective pharmacokinetics and inversion of (R)- ketoprofen in healthy volunteers.Sex and Food Influence on Intestinal Absorption of Ketoprofen Gastroresistant Formulation.Stereoselective Pharmacokinetics of Ketoprofen After Oral Administration of Modified-Release Formulations in Caucasian Healthy Subjects.Effect of oral KETOPROFEN treatment in acute respiratory disease outbreaks in finishing pigs.
P2860
Q28710485-51C4A4A1-C7BB-4D90-B7B3-DE9B75A97E37Q32000282-9F474432-59A9-4F30-9795-148F0FBA55B0Q33567391-9D4EBD30-99F6-4839-84F5-AA2FDF85715FQ34345693-606038DD-8CC5-47C8-A5E5-ADA5DEFD59B5Q34347138-3832A31E-EE30-45A5-BB5C-39ACF7F9805AQ35954561-C27C8105-A7D9-464A-BB66-513814D257FDQ36148700-4AAC6F32-33AD-45DE-B17B-60AF5F80CD7DQ38705829-D6A1D362-233C-4FA3-9778-95F737E3DB13Q38925148-B82A61E1-04C8-4928-8F48-71045082A676Q39428916-E4BF9610-AECB-405E-872C-095DBBA9F7EBQ40532053-FC5A4816-CE04-4D41-9364-26FAC4DF92B6Q40950958-2AB02BD6-121B-414C-AE6E-3A132E7D86A8Q41113849-E9A08324-908C-426E-B74C-E1F586A86EF1Q41113860-199BAC38-5C9E-462A-AD25-D25080DEF43FQ41820962-433C1D6A-424B-44E8-8148-662263EC9C61Q41990652-81FC73B2-61D0-4785-B433-43E19240C908Q42099116-9B312CB9-F0B7-4FA5-9566-DD08D97C6935Q43786966-1DC1F9B6-C85A-4092-A175-1BABD1B3EEABQ43961618-BAD67768-20FC-4551-BAF9-C3A36AE97AF7Q44362857-8C8C9C7B-7671-49F9-B225-A0BE6C2DBBBBQ44870412-D3AE2B5A-717E-4C6F-97B7-E6CAB01C061AQ44876365-832CA777-1254-440B-8C47-4E5D63E56861Q46413707-77655615-F6BB-40E0-86F0-A61323FB938AQ48159372-502524EA-7D6C-450B-9F1C-774E7AE94F3AQ48235206-DD6FA555-6274-40CF-8734-4EBC8136351BQ50098732-D5B1BAE0-B024-433F-B57D-C69C35B8076CQ50098761-5720F5C7-4293-4591-89FC-350660DE3EC7Q50895318-AFC900C3-6F61-44BB-A5EC-D05525D051A1Q51284844-9DB0A845-CD18-4CD4-8A23-2CDDF486A5FEQ51293808-B9916FB4-3EB6-4C6F-AD52-6919EA2EF6A0Q51783413-3E753A17-A942-430B-AD2E-B80D68303A47
P2860
Clinical pharmacokinetics of ketoprofen and its enantiomers.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Clinical pharmacokinetics of ketoprofen and its enantiomers.
@en
Clinical pharmacokinetics of ketoprofen and its enantiomers.
@nl
type
label
Clinical pharmacokinetics of ketoprofen and its enantiomers.
@en
Clinical pharmacokinetics of ketoprofen and its enantiomers.
@nl
prefLabel
Clinical pharmacokinetics of ketoprofen and its enantiomers.
@en
Clinical pharmacokinetics of ketoprofen and its enantiomers.
@nl
P1476
Clinical pharmacokinetics of ketoprofen and its enantiomers.
@en
P2093
P304
P356
10.2165/00003088-199019030-00004
P577
1990-09-01T00:00:00Z
P6179
1052023387